Description: Taj Pharma India is well established Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection IP 0.5MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP 0.5MIU is given under the supervision of a healthcare professional. You should not self-administer Colistimethate Sodium for Injection IP at home. The dose and duration will be decided by your doctor based on the severity and type of infection you have. Get the injection regularly for as long as your doctor has prescribed to get maximum benefits. Taj Pharma is a reputed pharmaceutical company in India, renowned for manufacturing and exporting Colistimethate Sodium for Injection IP 0.5MIU. This life-saving antibiotic is extensively used to treat severe multidrug-resistant bacterial infections in critically ill patients, especially in hospital and ICU settings. Headquartered in Vapi, Gujarat, Taj Pharma delivers high-quality, GMP-compliant injectable formulations across India, Africa, the Middle East, and LATAM regions. Colistimethate Sodium Injection is administered intravenously under medical supervision and plays a crucial role in managing infections caused by resistant Gram-negative bacteria. Taj Pharma ensures that each batch meets international quality and safety standards, backed by ISO, WHO-GMP certifications, and state-of-the-art manufacturing facilities. With a wide PAN India presence and global export network, Taj Pharma also offers PCD Pharma Franchise and third-party manufacturing services, ensuring cost-effective, compliant, and timely supply solutions. The product is safe under breastfeeding but requires caution during pregnancy and in patients with kidney disease. Taj Pharma is your trusted partner for Colistimethate Sodium for Injection IP 0.5MIU, offering unmatched reliability, competitive pricing, and complete regulatory support. Taj Pharma India is Best Known Manufacturer, Exporter and Supplier Colistimethate Sodium for Injection IP 0.5MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 275 KB
